Onco Therapies Limited (OTL), the wholly-owned oncology subsidiary of Strides, has received the UK's approval for Oxaliplatin injections in strengths of 5 mg per 10 ml, 5 mg per 20 ml and 5 mg per 40 ml, Strides Arcolab said in a statement.
"The current approval is from UK and approval for the rest of the European countries is expected shortly," it added.
2700
4500
400
800
405
999
799
1699
10800
16200
39353
56219
487
799
9450
18899
14664
29328
398
699